期刊文献+

血小板参与动脉粥样硬化斑块形成的分子途径 被引量:13

The Molecular Mechanism of Platelets in Atherosclerotic Plaque Formation
原文传递
导出
摘要 血小板在血栓形成,血液凝固,维持血管稳态及修复血管损伤等生理病理过程中起重要作用。近年来研究发现血小板也可作为炎症细胞参与机体宿主防御,发挥免疫功能。动脉粥样硬化是一种慢性血管炎症性疾病,在血管炎症发生过程中,血小板可通过表面受体或释放储存在血小板颗粒中的分子促进血小板与炎症细胞(如血管内皮细胞、平滑肌细胞、单核细胞)相互作用,从而参与动脉粥样硬化发生。本文主要围绕血小板参与动脉粥样硬化斑块形成的途径,及其作为动脉粥样硬化早期防治靶点的最新进展进行综述。 Platelets play an important role in the physiological and pathological processes including thrombosis,coagulation,vascular homeostasis,and repairing.In recent years,accumulated evidence revealed that platelets could act as inflammatory cells participating in the host defense and inducing immune response.Atherosclerosis is a chronic vascular inflammatory disease.During vascular inflammation,platelets interact with inflammatory cells(such as vascular endothelial cells,smooth muscle cells,monocytes)through surface receptors or cytokines stored in platelet dense orαgranules participating in the atherogenesis.This review focuses on the molecular pathways of platelets in the formation of atherosclerotic plaque and their latest progress in targeted therapy for atherosclerosis treatment.
作者 唐朝君 王蕾 朱力 TANG Chao-jun;WANG Lei;ZHU Li(Cyrus Tang Hematology Center,Cyrus Tang Medical Institute,Soochow University,Suzhou,215123;Suzhou Key Laboratory of Thrombus and Vascular Disease,Suzhou,215123;Collaborative Intwvation Center of Hematology of Jiangsu Province,Suzhou,215123,China)
出处 《中国分子心脏病学杂志》 CAS 2020年第4期3437-3444,共8页 Molecular Cardiology of China
关键词 血小板 动脉粥样硬化 血管炎症 分子靶标 Platelets Atherosclerosis Vascular inflammation Molecular pathway
  • 相关文献

参考文献1

二级参考文献33

  • 1Doring Y,Pawig L,Weber C,et al.The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease[J].Front Physiol, 2014 (5) : 212.
  • 2Duda DG,Kozin SV,Kirkpatriek ND,et al.CXCL12(SDFlalpha)- CXCR4/CXCR7 pathway inhibition:an emerging sensitizer for anti- cancer therapies? [J].Clin Cancer Res, 2011,17 ( 8 ) : 2074-2080.
  • 3Rankin SM.Chemokines and adult bone marrow stem cells[J].Im- munol Lett,2012,145 (1-2) :47-54.
  • 4Akhtar S,Gremse F,K/essling F,et al.CXCL12 promotes the sta- bilization of atherosclerotic lesions mediated by smooth muscleprogeni- tor cells in Apoe-deficient mice[J].Arterioscler Thmmb Vasc Biol, 2013, 33(4) :679-686.
  • 5Tmbelja A, MacArthur JW, Sarver JJ, et al.Bioengineered stromal cell-derived factor-let analogue delivered as .an angiogenic therapy significantly restores viscoelastic material properties of infarcted cardiac musele[J].J Biomech Eng,2014,136(8) :4501-4505.
  • 6Balabanian K,Lagane B,Infantino S,et al.The chemokine SDF-1/ CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes[J].J Biol Chem, 2005,280(42) : 35760-35766.
  • 7Ransohoff RM.Chemokines and chemokine receptors:standing at the crossroads of immunobiology and neurobiology[J].Immunity, 2009,31 (5) : 711-721.
  • 8Bachelerie F,Ben-Baruch A, Burkhardt AM,et al.Update on the ex- tended family of chemokine receptors and introducing a new nomencla- ture for atypical chemokine receptors[J].Pharmacol Rev, 2013,66 ( 1 ) : 71 - 79.
  • 9Graham GJ,Locati M,Mantovani A,et al.The biochemistry and bi- ology of the atypical ehemokine receptors[J].Immunol Lett,2012,145 (1-2) :30-38.
  • 10Rajagopal S,Kim J,Ahn S,et al.Beta-arrestin- but not G protein- mediated signaling by the decoy receptor CXCR7[J].Proc Natl Acad SciU S A,2010,107(2):628-632.

共引文献4

同被引文献173

引证文献13

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部